Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AKR7A2 pseudogene 1 (AKR7A2P1, AFARP1) is a processed pseudogene in the human genome related to the aldo-keto reductase family 7 member A2 gene (AKR7A2). Unlike its functional counterpart AKR7A2, which is involved in detoxification of aldehydes and the biosynthesis of gamma-hydroxybutyrate[1][2], AKR7A2P1 does not encode a functional protein product and is not considered a molecular target for therapeutic intervention[3].\nThe confusion may arise because its name is similar to AKR7A2 (a detoxifying enzyme with multiple biological and clinical roles), but as a *pseudogene* it does not share those functions or targetability[3]. If you are seeking information about an actual targetable protein or enzyme, search instead for “Aldo-keto reductase family 7 member A2 (AKR7A2)” rather than AKR7A2P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AKR7A2 pseudogene 1 (AKR7A2P1).